Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 09:32 am Purchase |
2025-03-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
Woodline Partners LP | 5,916,167 6.800% |
5,916,167 (New Position) |
Filing History |
| 2025-05-14 4:18 pm Unchanged |
2025-05-07 | 13D | Tenaya Therapeutics, Inc. TNYA |
The Column Group III, LP | 49,313,559 30.300% |
0 (Unchanged) |
Filing History |
| 2025-05-07 09:31 am Purchase |
2025-03-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
Empery Asset Management, LP | 8,727,314 9.960% |
8,727,314 (New Position) |
Filing History |
| 2025-03-07 8:22 pm Purchase |
2025-03-04 | 13D | Tenaya Therapeutics, Inc. TNYA |
Casdin Capital, LLC | 6,732,971 4.300% |
305,771 (+4.76%) |
Filing History |
| 2025-03-07 7:50 pm Purchase |
2025-03-05 | 13D | Tenaya Therapeutics, Inc. TNYA |
The Column Group III, LP | 49,313,559 32.000% |
35,714,284 (+262.62%) |
Filing History |
| 2025-03-06 10:52 am Sale |
2025-02-28 | 13G | Tenaya Therapeutics, Inc. TNYA |
JPMORGAN CHASE & CO JPM |
2,283,914 2.800% |
-2,871,036 (-55.69%) |
Filing History |
| 2025-02-14 6:42 pm Sale |
2024-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
RA CAPITAL MANAGEMENT L.P. | 0 0.000% |
-7,980,736 (Position Closed) |
Filing History |
| 2025-02-10 12:51 pm Purchase |
2024-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
JPMORGAN CHASE & CO JPM |
5,154,950 6.500% |
5,154,950 (New Position) |
Filing History |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
BlackRock Inc. BLK |
5,296,476 6.700% |
1,509,652 (+39.87%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Tenaya Therapeutics, Inc. TNYA |
RA CAPITAL MANAGEMENT L.P. | 7,980,736 9.990% |
1,032,500 (+14.86%) |
Filing History |
| 2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | Tenaya Therapeutics, Inc. TNYA |
T. Rowe Price Associates, Inc. | 3,028,435 3.800% |
-1,516,108 (-33.36%) |
Filing History |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
RA CAPITAL MANAGEMENT L.P. | 6,948,236 9.990% |
519,753 (+8.09%) |
Filing History |
| 2024-02-14 4:19 pm Purchase |
2024-02-12 | 13D | Tenaya Therapeutics, Inc. TNYA |
The Column Group III, LP | 13,599,275 17.700% |
2,229,001 (+19.60%) |
Filing History |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
T. Rowe Price Associates, Inc. | 4,544,543 6.700% |
72,341 (+1.62%) |
Filing History |
| 2024-02-14 07:29 am Sale |
2023-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
RTW Investments, LP | 0 0.000% |
-2,458,750 (Position Closed) |
Filing History |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
BlackRock Inc. BLK |
3,786,824 5.600% |
3,786,824 (New Position) |
Filing History |
| 2023-02-21 5:26 pm Purchase |
2023-02-08 | 13D | Tenaya Therapeutics, Inc. TNYA |
The Column Group III, LP | 11,370,274 17.800% |
1,754,890 (+18.25%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
RA CAPITAL MANAGEMENT L.P. | 6,428,483 9.990% |
2,876,975 (+81.01%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
T. Rowe Price Associates, Inc. | 4,472,202 6.700% |
1,478,699 (+49.40%) |
Filing History |
| 2023-02-09 12:39 pm Sale |
2023-02-09 | 13G | Tenaya Therapeutics, Inc. TNYA |
FMR LLC | 2,830,476 4.236% |
-294,822 (-9.43%) |
Filing History |